Skip to content

Clinical trials

Completed Sexually Transmitted Diseases trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Sexually Transmitted Diseases Status: Completed Country / region: United States Clear all

215 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20015
20025
20034
20046
200510
20065
20073
20087
20098
201010
201111
20129
201310
20148
201516
201611
201715
20188
201916
20207
20218
20227
20238
20245
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed215

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Centers for Disease Control and Prevention14
Emory University12
University of California, San Francisco10
University of Pennsylvania9
Columbia University7
National Institute of Allergy and Infectious Diseases (NIAID)6
The Miriam Hospital6
The University of Texas Health Science Center, Houston6
University of North Carolina, Chapel Hill6
RTI International5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Sexually Transmitted Diseases215
HIV Infections57
Acquired Immunodeficiency Syndrome28
Substance-Related Disorders20
Gonorrhea19
Chlamydia Infections16
Syphilis6
Hepatitis3
Opioid-Related Disorders3
Trichomonas Infections3

Trials

Showing 1 to 25 of 215. Each trial links to its page on Pharma Observatory.

115 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.